Proficiency Testing and Standardization of Prothrombin Time: Effect of Thromboplastin, Instrumentation, and Plasma-Reference-Cited by-同舟云学术

Proficiency Testing and Standardization of Prothrombin Time: Effect of Thromboplastin, Instrumentation, and Plasma

Published:1984-12-01 Issue:6 Volume:82 Page:688-699
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Van Den Besselaar Antonius M. H. P.¹,Evatt Bruce L.¹,Brogan Donna R.¹,Triplett Douglas A.¹

Affiliation:

1. Host Factors Division, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, Department of Health and Human Services, and Department of Statistics and Biometry, Emory University, Atlanta, Georgia; Academisch Ziekenhuis Leiden, 2333 AA Leiden, The Netherlands; and College of American Pathologists, Skokie, Illinois

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/82/6/688/26432353/ajcpath82-0688.pdf

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Routine Coagulation;Clinics in Laboratory Medicine;2024-09

2. From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories;Seminars in Thrombosis and Hemostasis;2022-09-29

3. Viscoelastic monitoring in trauma resuscitation;Transfusion;2020-10

4. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.;Journal of the American College of Cardiology;2003-05

5. American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy;Circulation;2003-04